The Federal Trade Commission says the settlement will increase transparency and competition across the entire drug supply chain.
Overview
Latest News
Further Reading
Companies involved in a medical device acquisition face record penalties after failing to comply with Hart Scott Rodino Act reporting requirements.
Reed Smith attorneys Julia Ensor and Rebecca Fike drew on their experience at the FTC and SEC respectively to weigh in on the implications of the Supreme Court's ruling.
Move introduces fresh legal uncertainty about the independence of the US FTC that may complicate legal foundations supporting EU–US data sharing.
Federal antitrust suit claims two pharmacy benefits managers worked together to suppress pharmacy reimbursements rates, fueling ongoing scrutiny of PBM practices.
GRIP Extra
Premium
GRIP Extra: SEC, CFTC mull coordinated risk calculations, BoE sets out stablecoin framework
Our in-brief roundup of notable stories from the last week.
In an amicus brief, the Commission argues that courts should evaluate monopolization claims based on the effects of a company’s conduct on competition, not on an intention to harm competitors.
Key enforcement priorities, rule changes, litigation trends, and disclosure expectations shaping the federal privacy and cybersecurity landscape in 2026.
Further Reading
